The impact of systems approaches on biological problems in drug discovery

被引:154
作者
Hood, L
Perlmutter, RM
机构
[1] Inst Syst Biol, Seattle, WA 98103 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1038/nbt1004-1215
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:1215 / 1217
页数:3
相关论文
共 11 条
[1]   Prospects for productivity [J].
Booth, B ;
Zemmel, R .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :451-457
[2]   Genomic sciences and the medicine of tomorrow [J].
Drews, J .
NATURE BIOTECHNOLOGY, 1996, 14 (11) :1516-&
[3]   An integrative biology approach for analysis of drug action in models of human vascular inflammation [J].
Kunkel, EJ ;
Dea, M ;
Ebens, A ;
Hytopoulos, E ;
Melrose, J ;
Nguyen, D ;
Ota, KS ;
Plavec, I ;
Wang, Y ;
Watson, SR ;
Butcher, EC ;
Berg, EL .
FASEB JOURNAL, 2004, 18 (09) :1279-+
[4]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[5]   Understanding 'global' systems biology: Metabonomics and the continuum of metabolism [J].
Nicholson, JK ;
Wilson, ID .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (08) :668-676
[6]   EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].
Paez, JG ;
Jänne, PA ;
Lee, JC ;
Tracy, S ;
Greulich, H ;
Gabriel, S ;
Herman, P ;
Kaye, FJ ;
Lindeman, N ;
Boggon, TJ ;
Naoki, K ;
Sasaki, H ;
Fujii, Y ;
Eck, MJ ;
Sellers, WR ;
Johnson, BE ;
Meyerson, M .
SCIENCE, 2004, 304 (5676) :1497-1500
[7]  
*PHAMR RES MAN AM, 2004, PHARM IND PROF 2004
[8]   Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine [J].
Weston, AD ;
Hood, L .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (02) :179-196
[9]  
WESTON AD, 2004, S QUANTITATIVE BIOL, V68, P345
[10]  
2004, DRUG WEEK 0625